Biologics Manufacturing Facilities To Access
Contract Manufacturing Organizations to Access
This tracker provides an in-depth overview of the APAC Biologics CMOs and their manufacturing capabilities. Through this tracker IMAPAC aims to assist organizations to keep track of CMOs in the APAC region, identify any opportunities for strategic partnership or investments to speed biologics product to market.
Manufacturer's name, location, service offering capabilities, scale of manufacturing, technology platforms, products and sub-products manufactured, current & completed projects of CMOs, facility name, location, establishment year, facility size & capacity, annual production, batch size, bioprocessing equipment, bioreactors, expression system, manufacturing process type, regulatory compliance & certifications, sponsors & collaborations, expansions plans of CMOs and other parameters.
China (39%), India (15%), South Korea (11%), Taiwan (9%), Japan (8%), Singapore (5%), Australia (5%), Malaysia (4%), Thailand (2%), Hong Kong (1%), Indonesia (1%)
Key Companies Covered
Serum Institute of Technology, Cell Therapies Pty Ltd, CMAB Biopharma, Lonza, Samsung Biologics, United Biopharma, Wuxi Biologics among other key CMOs